This program was possible with support from Bayer.
Rashid K. Sayyid, MD, MSc, discusses the role of combination therapy in metastatic castrate-resistant prostate cancer.
Rashid K. Sayyid, MD, MSc
Advertisement
Articles by Rashid K. Sayyid, MD, MSc
This program was possible with support from Bayer.
Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.
This program was possible with support from Bayer.
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer.
This program was possible with support from Bayer.
An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer.
This program was possible with support from Bayer.
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
This program was possible with support from Bayer.
Rashid K. Sayyid, MD, MSc, describes the staging and risk stratification process for patients with prostate cancer and their effect on prognosis.
Advertisement
Latest Updated Articles
Treatment Options for Nonmetastatic CRPCOctober 19th 2023
- Systemic Therapy for Prostate Cancer
October 5th 2023
- Overview of Castrate-Resistant Prostate Cancer (CRPC)
October 19th 2023
- Prostate Cancer Prognosis and Risk Stratification
September 21st 2023
- Treatment Approach for Patients With Metastatic CRPC
October 19th 2023
- The Role of Combination Therapy in mCRPC
October 26th 2023
Advertisement
Advertisement
Trending on CURE
1
Clock Touches: An Advanced Balance Exercise for Patients with Cancer
2
Wildfire Smoke and Cancer Risk: What Patients Should Know
3
Balance Exercises for Patients With Cancer: How the Single-Leg Stand Builds Stability
4
Family History of Cancer Fuels Oncology Nurse's Passion for Patient Care
5